Alzheimer & Parkinson
Lipid homeostasis and cellular metabolism in neurodegenerative diseases: A maturing framework to guide therapeutic development
Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies have long been viewed through the lens of protein aggregation. Emerging evidence, however, highlights lipid transfer, load, metabolism, and cellular homeostasis as upstream drivers of pathology. This perspective integrates established neurobiological, genetic, and mechanistic evidence of lipid dysfunction and outlines how these pathways can guide patient stratification, biomarker discovery,...
Multimodal MRI reveals brain structural and functional abnormalities associated with wearing-off phenomenon in Parkinson's disease
CONCLUSIONS: This preliminary single-center cross-sectional study revealed significant differences in brain structure and function between PD-WO and PD-nWO patients. These findings provide a better understanding of the neural mechanisms behind the WO phenomenon in PD and suggest potential therapeutic targets.
Obesity pharmacotherapies and cognition
Pharmacotherapies for obesity and type 2 diabetes are increasingly being evaluated for their effects on cognition and brain health. Evidence from preclinical models, observational cohorts, and clinical trials has intensified interest, but findings remain mixed. A central challenge is to determine whether potential cognitive effects arise from direct actions on neural circuits, indirect consequences of improved cardiometabolic health, or both. This Review examines the evidence across...
Physiological APP processing is required for synaptic plasticity and cognition
While the accumulation of Aβ peptides, derived by proteolytic cleavage from the amyloid precursor protein APP, constitutes a hallmark of Alzheimer's disease, the question of whether endogenous, physiological APP processing serves an essential role for normal brain function(s) has remained elusive. Here, we modified the mouse APP locus to delete the endogenous α- and β-secretase sites (APP residues S592-G621) while preserving the transmembrane topology and the APP C-terminus. These novel knockin...
APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer's disease
The apolipoprotein E (APOE) gene is the strongest genetic risk factor for Alzheimer's disease (AD), influencing amyloid-β (Aβ) aggregation, clearance, and glial function. While APOE4 promotes Aβ pathology and APOE2 is protective, how these opposing alleles interact in the heterozygous APOE2/4 state remains unknown. Here, using littermate-controlled heterozygous APOE mice (APOE2/3, APOE3/4, and APOE2/4) alongside APOE3/3 controls crossed with 5xFAD mice, we show that APOE3/4 mice exhibit...
Parkinson's: beyond the brain
No abstract
Language modeling screens Parkinson's disease with self-reported questionnaires
Parkinson's disease (PD) is a growing public health challenge as populations age. Current diagnosis relies on motor symptoms and invasive procedures, making early detection difficult. Here we present Quest2Dx, a generalized artificial intelligence model that analyzes health questionnaires to enable low-cost, non-invasive PD screening. Conventional models are built for each questionnaire, and missing responses degrade their performance. Quest2Dx uses language modeling to encode the meaning of...
Screening for Parkinson's disease across questionnaires using language models
No abstract
Progress accelerates in Parkinson's treatments
No abstract
Six highlights from Parkinson's disease research
No abstract
Replacing the neurons that Parkinson's destroys
No abstract
Could chemicals contribute to Parkinson's?
No abstract
How the brain protects itself from Parkinson's disease
No abstract
Fine-tuning brain stimulation to fight Parkinson's disease
No abstract
How a once-controversial idea is advancing understanding of Parkinson's disease
No abstract
Clearing the way for a transformative stem-cell treatment for Parkinson's disease
No abstract
P2RX7 drives inflammatory microglia and pathogenic extracellular vesicle secretion in tauopathy
P2X purinoreceptor 7 (P2RX7), an ATP-gated ion channel, contributes to Alzheimer's disease (AD) progression, but its molecular mechanisms remain unclear. Here, we show that genetic disruption of P2rx7 mitigates brain atrophy, tau accumulation, and cognitive impairment in PS19 mice. Microglia-specific, but not astrocyte-specific, deletion of P2rx7 suppresses tau propagation. Single-cell RNA sequencing identifies a previously unrecognized first-responding microglial state (FRM) with prominent...
Tau-driven hyperexcitability of locus coeruleus noradrenergic neurons underlies sleep fragmentation and cognitive decline in mice
Early sleep disruption is a hallmark of preclinical Alzheimer's disease (AD), but its underlying mechanisms are unclear. The locus coeruleus (LC) dopamine-β-hydroxylase noradrenergic (LC^(DBH)) neurons are vulnerable to early tau pathology in AD. Using P301S transgenic mice and cell-type-specific tau overexpression models, we show that pathological tau accumulation selectively increases the intrinsic excitability of LC^(DBH) neurons. Tau-induced neuronal hyperactivity disrupts sleep homeostasis,...
Common transcriptional changes in the brain during hibernation and Alzheimer's disease
Hibernation demands rapid brain adaptations, involving cycles of reduced metabolic rate during torpor, followed by brief periods of arousal. Previous studies show hibernation induces a drastic increase in Tau hyperphosphorylation, but a mechanistic connection to disease remains unclear. Using single-nucleus RNA sequencing on hippocampi of golden hamsters, we unveil large transcriptional shifts across the hibernation cycle in all cell types, especially glia. Common transcriptional changes in...
A functional connectome identifies vulnerability to cognitive decline and Alzheimer's disease progression
Identifying the neurobiological basis of cognitive vulnerability is essential for preventing Alzheimer's disease (AD). We derived the Alzheimer's Resilience-Vulnerability Connectome (ARC) by contrasting SuperAgers (SA), an extreme phenotype of preserved late-life memory, with AD using resting-state fMRI. ARC distinguished SA from AD in a discovery cohort (N = 290; AUC = 0.85) and replicated independently (N = 143), involving prefrontal, temporal, and insular networks and associating with brain...
Alzheimer and Parkinson: Latest results from PubMed
Subscribe to Alzheimer & Parkinson feed